WDFY2 potentiates hepatic insulin sensitivity and controls endosomal localization of the insulin receptor and IRS1/2
Ada Admin, Wei‐Guo Zhu(Shenzhen University), Xin Yang(Nanjing Forestry University), Nan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xue Li(Qingdao Agricultural University), Lina Wang(Hubei University of Science and Technology), Yuan Tian, Luyao Zhang, Wen He(Beijing Chemical Industry Research Institute (China)), Hongquan Zhang(Nanjing University of Posts and Telecommunications), Wan Fu(Shanghai Ninth People's Hospital), Tianyun Hou(Peking University), Xifeng Lu, Fengjie Yuan
Cited by 0
Related Papers
Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency
|Cell|2017|516
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
|Frontiers in Cell and Developmental Biology|2020|362
Evaluation of cell-free DNA approaches for multi-cancer early detection
|Cancer Cell|2022|311
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
|Signal Transduction and Targeted Therapy|2023|289
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
|Cancer Research|2017|237